About this episode
Remdesivir a drug eventually rejected as a treatment for Ebola seems to have aided recovery in a trial with more than a thousand Covid -19 patients. Researchers are cautious but hopeful; a leading health official in the US has made comparisons with the impact of game changing drugs used to treat HIV.
In contrast an organisation researching the mechanisms by which bat coronaviruses infect humans has had its funding cut following criticism from President Trump.
A scheme to help manufacture ventilators and protective equipment worldwide has seen some success with a simple ventilator they developed, now in use in hospitals.
And we look at climate change –with this year set for extreme weather
(Image: Liberian photographer Alphanso Appleton took this picture of a schoolgirl and sent it to the Wellcome Trust, to express thanks for their and others’ efforts to develop an Ebola vaccine. Credit: Alphanso Appleton/Wellcome Trust)
Presenter: Roland Pease Producer: Julian Siddle
Get every episode summarized
Each time Science In Action publishes, we email you a written briefing from the transcript — the topics, who appeared, and any specific claims, with the ad reads skipped.
Email me new episodesFree for 3 shows. No card needed.
No transcript yet
This episode has not been transcribed. Request it and it moves to the front of the queue.
More episodes
More from Science In Action
How science got here, and where next
Science In Action
Coral extinctions and chalky unknowns
Science In Action
Paris agreement impacts and drought realities
Science In Action
Old faces and big spaces in small places
Science In Action